See more news releases in: Biotechnology, Medical Pharmaceuticals, Pharmaceuticals, New Products & Services, Surveys, Polls and Research
Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies Now Available at ReportsandReports
DALLAS, Texas, September 2, 2010 /PRNewswire/ -- ReportsandReports announces it will carry Manufacturing of Biologics (http://www.reportsandreports.com/market-reports/manufacturing-of-biologics-i ncreasing-demand-for-monoclonal-ant/) - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies Market Research Report in its store.
Browse the complete Report on: http://www.reportsandreports.com/market-reports/manufacturing-of-biologics-in creasing-demand-for-monoclonal-ant/
Search More Then 45000 Market Research Reports at ReportsandReports (http://www.reportsandreports.com/)
(Due to the length of this URL, it may be necessary to copy and paste this hyperlink into your Internet browser's URL address field. Remove the space if one exists.)
GBI Research's report, "Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies", provides the key data and analyzes the major challenges and drivers for the biomanufacturing industry. The report also analyzes the strengths, weaknesses of and opportunities for the stakeholders in the manufacturing of biologics. The report also discusses the key market drivers and barriers for the growth of biomanufacturing in the pharmaceutical ( http://www.reportsandreports.com/market-research/pharmaceuticals/) and biotech industry.
The report is based on proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts to provide a comprehensive view of the manufacturing of biologics.
Scope
The scope of this report includes:
- Opportunities and challenges for manufacturers of biologics in the
pharmaceuticals industry
- Market revenues and forecasts for biologics manufacturing in the global
pharmaceutical industry from 2009 to 2016.
- The key geographies including the US, Europe, Japan and Emerging
Hotspots such as India, Singapore and China.
- Processes involving the manufacturing of biologics including upstream
and downstream bioprocessing.
- Technology trends in upstream and downstream bioprocessing that shape
the biomanufacturing industry and regulatory trends in the key markets.
- Production capacities for the mammalian and microbial manufacturing
facilities in the key regions.
- Qualitative analysis of the market drivers, barriers, future outlook
and challenges for the manufacturing of biologics in the pharmaceutical
industry
- Analysis of competitive landscape and the leading market players.
Reasons to buy
The report will enhance your decision making capability. It will allow
you to:
- Formulate strategies to increase your company's growth by understanding
the new growth opportunities in the market for manufacturing of
biologics
- Work around the regulatory and technology hurdles by identifying the
key trends shaping and driving the market for biomanufacturing.
- Differentiate yourself from competitors and develop new solutions for
the biomanufacturing industry by understanding the current competitive
landscape and how it is evolving to meet the increasing demands
- Draft efficient strategies by understanding best practices, identifying
key winners and losers and who is best positioned to take advantage of
the emerging market opportunities.
- Make more informed business decisions from the insightful and in-depth
analysis of the market for biomanufacturing by analyzing the key
technology trends that shape the growth of this market
Read Full TOC of Report : http://www.reportsandreports.com/market-reports/manufacturing-of-biologics-in creasing-demand-for-monoclonal-ant/
Browse all Pharmaceuticals Reports at
http://www.reportsandreports.com/market-research/pharmaceuticals/
Browse All GBI Research Reports at
http://www.reportsandreports.com/Publishers/gbi-research/
About Us
ReportsandReports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.
(Due to the length of these URLs, it may be necessary to copy and paste the hyperlinks into your Internet browser's URL address field. Remove the space if one exists.)
Contact:
Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
http://www.reportsandreports.com/
http://reportsnreports.wordpress.com/
http://reportsandreports.blogspot.com/
SOURCE MarketsandMarkets
Back to top
Custom Packages
Browse our custom packages or build your own to meet your unique communications needs.
PR Newswire Membership
Fill out a PR Newswire membership form or contact us at (888) 776-0942.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.
Featured Video
More in These Categories
Journalists and Bloggers
![]()
Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.
View and download archived video content distributed by MultiVu on The Digital Center.
Free Investing Newsletter from Investor Uprising!
Learn to navigate the world's financial system and profit from leading companies.
Register for Investor Uprising, the people's investment site, for a free weekly newsletter, information, education and premium research including our latest IU Confidential Report - "All The Glitters: The Ultimate Gold Report".
